tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BNTC Stock Latest News

Benitec Biopharma Reports Promising Interim Study Results
Company AnnouncementsBenitec Biopharma Reports Promising Interim Study Results
6d ago
8K
BNTC
Benitec Biopharma’s BB-301 shows efficacy in Phase 1b/2a study of OPMD
PremiumThe Fly
Benitec Biopharma’s BB-301 shows efficacy in Phase 1b/2a study of OPMD
7d ago
BNTC
Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study
PremiumPress Releases
Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study
7d ago
BNTC
Benitec Biopharma Welcomes Kishan Mehta to Its Board
PremiumCompany Announcements
Benitec Biopharma Welcomes Kishan Mehta to Its Board
20d ago
8K
BNTC
Benitec Biopharma appoints Kishen Mehta to board of directors
PremiumThe Fly
Benitec Biopharma appoints Kishen Mehta to board of directors
21d ago
BNTC
Benitec Biopharma initiated with an Overweight at Piper Sandler
PremiumThe FlyBenitec Biopharma initiated with an Overweight at Piper Sandler
1M ago
BNTC
Benitec Biopharma files to sell 32.87M shares of common stock for holders
PremiumThe Fly
Benitec Biopharma files to sell 32.87M shares of common stock for holders
2M ago
BNTC
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
PremiumPress Releases
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
2M ago
BNTC
Benitec Biopharma reports Q3 EPS ($1.64) vs. ($2.67) last year
PremiumThe Fly
Benitec Biopharma reports Q3 EPS ($1.64) vs. ($2.67) last year
2M ago
BNTC
Benitec Biopharma (BNTC) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Benitec Biopharma (BNTC) Q3 Earnings Cheat Sheet
2M ago
BNTC
Benitec Biopharma price target raised to $16 from $10 at JMP Securities
PremiumThe Fly
Benitec Biopharma price target raised to $16 from $10 at JMP Securities
3M ago
BNTC
Benitec Biopharma’s $40 Million Equity Financing Deal
PremiumCompany Announcements
Benitec Biopharma’s $40 Million Equity Financing Deal
3M ago
8K
BNTC
Benitec Biopharma Showcases Encouraging Clinical Trial Results
PremiumCompany AnnouncementsBenitec Biopharma Showcases Encouraging Clinical Trial Results
3M ago
8K
BNTC
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
PremiumPress Releases
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
3M ago
BNTC
Benitec Biopharma reports interim trial data for subject treasted with BB-301
PremiumThe Fly
Benitec Biopharma reports interim trial data for subject treasted with BB-301
3M ago
BNTC
Benitec Biopharma announces $40M oversubscribed private placement financing
PremiumThe Fly
Benitec Biopharma announces $40M oversubscribed private placement financing
3M ago
BNTC
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
PremiumPress Releases
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
3M ago
BNTC
Benitec Biopharma Awards Stock Options to Top Executives
PremiumCompany Announcements
Benitec Biopharma Awards Stock Options to Top Executives
5M ago
8K
BNTC
Benitec Biopharma files $125M mixed securities shelf
PremiumThe Fly
Benitec Biopharma files $125M mixed securities shelf
5M ago
BNTC
Benitec Biopharma price target raised to $10 from $8 at JMP Securities
PremiumThe FlyBenitec Biopharma price target raised to $10 from $8 at JMP Securities
5M ago
BNTC
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
PremiumPress Releases
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
5M ago
BNTC
Benitec Biopharma reports Q2 EPS ($2.64) vs ($3.34) last year
PremiumThe Fly
Benitec Biopharma reports Q2 EPS ($2.64) vs ($3.34) last year
5M ago
BNTC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >